Search Results 201-210 of 16201 for Chronic Lymphocytic Leukemia

1. Cancer Treatment Clinical Trials - Mayo Clinic Research

   Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...

2. Risk-Based Classification System of Patients with Newly Diagnosed Acute Lymphoblastic Leukemia - Mayo Clinic

   Gathering health information about patients with acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment.

3. Publications - Yucai Wang, M.D., Ph.D. - Mayo Clinic

   Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter? Blood Cancer ...

4. Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults - Mayo Clinic

   Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia ...

5. Chronic myelogenous leukemia - Diagnosis and treatment - Mayo Clinic

   Learn about chronic myelogenous leukemia symptoms and causes. Find out how CML is treated, including targeted therapy and bone marrow transplant.

6. Sikander Ailawadhi, M.D. - Doctors and Medical Staff - Mayo Clinic

   Chronic leukemias (chronic lymphocytic leukemi; CLL, chronic myeloid leukemia; CML); Clinical drug development in multiple myeloma and Waldenstrom's ...

7. Publications - Fiona E. Craig, M.D. - Mayo Clinic

   Chronic lymphocytic leukemia/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack ...

8. Yucai Wang, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

   Interests. Clinical trials for lymphoma and chronic lymphocytic leukemia. Novel therapeutics for hematological malignancies. Treatment and outcomes of lymphoma ...

9. A Study to Evaluate Outpatient Blinatumomab in Subjects with Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) - Mayo Clinic

   A Study to Evaluate Outpatient Blinatumomab in Subjects with Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) · Share · Facebook ...

10. Nilotinib and Combination Chemotherapy in Treating Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia - Mayo Clinic

    Nilotinib and Combination Chemotherapy in Treating Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase ...